霍洛苏里亚 (Holothuria leucospilota polysaccharide) 对减轻糖尿病病的影响,通过调节炎症来减轻糖尿病病的影响
Xin Wen1, Xin Zhang1, Wanting Wang1
1The Key Laboratory of Seafood Processing of Haikou, School of Food Science and Engineering, Hainan University, Haikou 570228, China.
International journal of biological macromolecules
|March 13, 2025
概括
霍洛瑞白血球多糖 (HLP) 通过减少炎症和改善功能,有效地治疗大鼠的糖尿病病 (DKD). 这项研究揭示了HLP.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 糖尿病病 (DKD) 是糖尿病的严重并发症,通常导致功能衰竭.
- 来自Holothuria leucospilota (HLP) 的多糖已显示出对2型糖尿病 (T2DM) 的潜在益处.
- 需要进一步研究HLP对DKD及其潜在机制的影响.
研究的目的:
- 研究HLP对糖尿病病 (DKD) 的治疗作用.
- 阐明HLP减轻DKD的分子机制.
主要方法:
- 自发的Goto-Kakizaki (GK) 鼠被用作DKD模型,Wistar鼠作为对照.
- 动物接受了HLP的胃内给药,持续了四周.
- 分析了功能标志物 (Scr,BUN,UA),指数,病理损伤,纤维化以及关键基因/蛋白质表达 (MIF,CD74,IL-6,PI3K,AKT,PCX).
主要成果:
- 在DKD大鼠中,HLP干预显著降低了指数,血清肌素 (Scr),血尿素 (BUN) 和尿酸 (UA) 水平.
- HLP治疗缓解了病理损伤和纤维化.
- 高血压蛋白降低了炎症标志物 (MIF,CD74,IL-6) 的mRNA表达,并提高了PI3K,AKT和PCX的水平.
结论:
- HLP在缓解糖尿病病 (DKD) 中表现出显著的有效性.
- 高血压蛋白通过调节炎症路径和代谢过程来发挥其保护作用.
- HLP显示出作为一种潜在的治疗药物来管理DKD的前景.
相关概念视频
01:22Heart Failure Drugs: Diuretics
313
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
313
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
428
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
428
01:23Dipeptidyl Peptidase 4 Inhibitors
153
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
153